Chinese Journal of Dermatology ›› 2024, Vol. 57 ›› Issue (7): 656-660.doi: 10.35541/cjd.20240048
• Reviews • Previous Articles Next Articles
Liu Qingfeng, Liu Lian, Diao Ping, Li Xiaoxue, Zhang Ting, Chen Haotian, Liu Xu, Jiang Xian
Received:
2024-01-24
Revised:
2024-04-12
Online:
2024-07-15
Published:
2024-07-02
Contact:
Jiang Xian
E-mail:jiangxian@scu.edu.cn
Supported by:
Liu Qingfeng, Liu Lian, Diao Ping, Li Xiaoxue, Zhang Ting, Chen Haotian, Liu Xu, Jiang Xian. Diagnosis and treatment of port-wine stains-associated syndromes[J]. Chinese Journal of Dermatology, 2024, 57(7): 656-660.doi:10.35541/cjd.20240048
[1] | Higueros E, Roe E, Granell E, et al. Sturge⁃Weber syndrome: a review[J]. Actas Dermosifiliogr, 2017,108(5):407⁃417. doi: 10.1016/j.ad.2016.09.022. |
[2] | Fjær R, Marciniak K, Sundnes O, et al. A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge⁃Weber syndrome[J]. Hum Mol Genet, 2021,30(21):1919⁃1931. doi: 10.1093/hmg/ddab144. |
[3] | Sánchez⁃Espino LF, Ivars M, Antoñanzas J, et al. Sturge⁃Weber syndrome: a review of pathophysiology, genetics, clinical features, and current management approache[J]. Appl Clin Genet, 2023,16:63⁃81. doi: 10.2147/TACG.S363685. |
[4] | Sudarsanam A, Ardern⁃Holmes SL. Sturge⁃Weber syndrome: from the past to the present[J]. Eur J Paediatr Neurol, 2014,18(3):257⁃266. doi: 10.1016/j.ejpn.2013.10.003. |
[5] | Zallmann M, Mackay MT, Leventer RJ, et al. Retrospective review of screening for Sturge⁃Weber syndrome with brain magnetic resonance imaging and electroencephalography in infants with high⁃risk port⁃wine stains[J]. Pediatr Dermatol, 2018,35(5):575⁃581. doi: 10.1111/pde.13598. |
[6] | Yeom S, Comi AM. Updates on Sturge⁃Weber syndrome[J]. Stroke, 2022,53(12):3769⁃3779. doi: 10.1161/STROKEAHA. 122.038585. |
[7] | Mantelli F, Bruscolini A, La Cava M, et al. Ocular manifestations of Sturge⁃Weber syndrome: pathogenesis, diagnosis, and management[J]. Clin Ophthalmol, 2016,10:871⁃878. doi: 10. 2147/OPTH.S101963. |
[8] | Sabeti S, Ball KL, Bhattacharya SK, et al. Consensus statement for the management and treatment of Sturge⁃Weber syndrome: neurology, neuroimaging, and ophthalmology recommendations[J]. Pediatr Neurol, 2021,121:59⁃66. doi: 10.1016/j.pediatrneurol. 2021.04.013. |
[9] | Sikakulya FK, Egesa WI, Kiyaka SM, et al. A neonate with Klippel⁃Trénaunay syndrome: a case report[J]. J Med Case Rep, 2021,15(1):447. doi: 10.1186/s13256⁃021⁃03029⁃4. |
[10] | Naganathan S, Tadi P. Klippel⁃Trenaunay⁃Weber syndrome[M/OL]. Treasure Island (FL): StatPearls Publishing, 2024[2024⁃04⁃12]. https://www.ncbi.nlm.nih.gov/books/NBK558989/. |
[11] | Bastarrika G, Redondo P, Sierra A, et al. New techniques for the evaluation and therapeutic planning of patients with Klippel⁃Trénaunay syndrome[J]. J Am Acad Dermatol, 2007,56(2):242⁃249. doi: 10.1016/j.jaad.2006.08.057. |
[12] | 中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形的诊断及治疗指南(2019版)[J]. 组织工程与重建外科杂志, 2019,15(5):277⁃317. doi: 10.3969/j.issn.1673⁃0364. 2019.05.001. |
[13] | Zhai J, Zhong ME, Shen J, et al. Kyphoscoliosis with Klippel⁃Trenaunay syndrome: a case report and literature review[J]. BMC Musculoskelet Disord, 2019,20(1):10. doi: 10.1186/s12891⁃ 018⁃2393⁃z. |
[14] | Sandbank S, Molho⁃Pessach V, Farkas A, et al. Oral and topical sirolimus for vascular anomalies: a multicentre study and review[J]. Acta Derm Venereol, 2019,99(11):990⁃996. doi: 10.2340/00015555⁃3262. |
[15] | Canaud G, Lopez Gutierrez JC, Irvine AD, et al. Alpelisib for treatment of patients with PIK3CA⁃related overgrowth spectrum (PROS)[J]. Genet Med, 2023,25(12):100969. doi: 10.1016/j.gim.2023.100969. |
[16] | Banzic I, Brankovic M, Maksimović Ž, et al. Parkes Weber syndrome⁃diagnostic and management paradigms: a systematic review[J]. Phlebology, 2017,32(6):371⁃383. doi: 10.1177/0268355516664212. |
[17] | Flores Daboub JA, Grimmer JF, Frigerio A, et al. Parkes Weber syndrome associated with two somatic pathogenic variants in RASA1[J]. Cold Spring Harb Mol Case Stud, 2020,6(4):a005256. doi: 10.1101/mcs.a005256. |
[18] | Eng W, Sudduth CL, Konczyk DJ, et al. Parkes Weber syndrome with lymphedema caused by a somatic KRAS variant[J]. Cold Spring Harb Mol Case Stud, 2021,7(6):a006118. doi: 10.1101/mcs.a006118. |
[19] | Szeliga A, Spyt D, Maćków E, et al. Parkes Weber syndrome[J]. Journal of Education, Health and Sport, 2019,9(8):987⁃997. doi:10.5281/zenodo.3408576. |
[20] | Vidaurri⁃de la Cruz H, Tamayo⁃Sánchez L, Durán⁃McKinster C, et al. Phakomatosis pigmentovascularis ⅡA and ⅡB: clinical findings in 24 patients[J]. J Dermatol, 2003,30(5):381⁃388. doi: 10.1111/j.1346⁃8138.2003.tb00403.x. |
[21] | Torrelo A, Zambrano A, Happle R. Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularis[J]. Br J Dermatol, 2003,148(2):342⁃345. doi: 10.1046/j.1365⁃2133.2003.05118.x. |
[22] | Torchia D. Phacomatosis spilorosea versus phacomatosis melanorosea: a critical reappraisal of the worldwide literature with updated classification of phacomatosis pigmentovascularis[J]. Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica, 2021, 30(1): 27⁃30. doi: 10.15570/actaapa.2021.6. |
[23] | Polubothu S, Bender N, Muthiah S, et al. PTPN11 mosaicism causes a spectrum of pigmentary and vascular neurocutaneous disorders and predisposes to melanoma[J]. J Invest Dermatol, 2023,143(6):1042⁃1051.e3. doi: 10.1016/j.jid.2022.09.661. |
[24] | 李敏, 张守民, 尹光文, 等. 儿童色素血管性斑痣性错构瘤病10例分析[J]. 中国皮肤性病学杂志, 2018,32(6):654⁃657. doi: 10.13735/j.cjdv.1001⁃7089.201712083. |
[25] | Fageeh SM, Alhothali OS, Alharbi SF, et al. Diffuse capillary malformation with overgrowth (DCMO): a case report and literature review[J]. Cureus, 2023,15(3):e35776. doi: 10. 7759/cureus.35776. |
[26] | Lee MS, Liang MG, Mulliken JB. Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy[J]. J Am Acad Dermatol, 2013,69(4):589⁃594. doi: 10.1016/j.jaad.2013.05.030. |
[27] | Gonzalez ME, Burk CJ, Barbouth DS, et al. Macrocephaly⁃capillary malformation: a report of three cases and review of the literature[J]. Pediatr Dermatol, 2009,26(3):342⁃346. doi: 10. 1111/j.1525⁃1470.2009.00924.x. |
[28] | Mirzaa G, Dodge NN, Glass I, et al. Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures[J]. Neuropediatrics, 2004,35(6):353⁃359. doi: 10.1055/s⁃2004⁃830497. |
[29] | Alamar M, Candela S, Flor⁃Goikoetxea A, et al. Megalencephaly⁃capillary malformation syndrome and associated hydrocephalus: treatment options and revision of the literature[J]. Childs Nerv Syst, 2021,37(8):2441⁃2449. doi: 10.1007/s00381⁃021⁃05222⁃8. |
[30] | Postma JK, Zambonin JL, Khouj E, et al. Further clinical delineation of microcephaly⁃capillary malformation syndrome[J]. Am J Med Genet A, 2022,188(11):3350⁃3357. doi: 10. 1002/ajmg.a.62936. |
[31] | 唐金玲, 李珂瑶, 罗勇奇, 等. CLOVES综合征1例[J]. 中华皮肤科杂志, 2023,56(3):259⁃261. doi: 10.35541/cjd.20201198. |
[32] | Garreta Fontelles G, Pardo Pastor J, Grande Moreillo C. Alpelisib to treat CLOVES syndrome, a member of the PIK3CA⁃related overgrowth syndrome spectrum[J]. Br J Clin Pharmacol, 2022,88(8):3891⁃3895. doi: 10.1111/bcp.15270. |
[33] | Biesecker LG. Proteus syndrome[M]//John CC, Agatino B, David V, et al. Cassidy and Allanson′s management of genetic syndromes. 4th ed. New York: Wiley International Publishing, 2021: 763⁃773. doi: 10.1002/9781119432692.ch47. |
[34] | Panteliadis CP, Friedrich RE. Proteus syndrome[M]//Panteliadis CP, Benjamin R, Hagel C. Neurocutaneous disorders: a clinical, diagnostic and therapeutic approach. Cham: Springer International Publishing, 2022: 247⁃253. doi: 10.1007/978⁃3⁃030⁃87893⁃1_22. |
[35] | Manor J, Lalani SR. Overgrowth syndromes⁃evaluation, diagnosis, and management[J]. Front Pediatr, 2020,8:574857. doi: 10. 3389/fped.2020.574857. |
[36] | Wang MX, Kamel S, Elsayes KM, et al. Vascular anomaly syndromes in the ISSVA classification system: imaging findings and role of interventional radiology in management[J]. Radiographics, 2022,42(6):1598⁃1620. doi: 10.1148/rg. 210234. |
[37] | Lamberg O, Strome A, Pedersen E, et al. CLAPO syndrome[J]. Eur J Pediatr Dermatol, 2022,32(3):147⁃150. doi:10.26326/2281⁃9649.32.3.2384. |
[38] | González⁃Hermosa MR, Guerra E, Tuduri I, et al. CLAPO syndrome: effective response to treatment with oral rapamycin[J]. Dermatol Ther, 2019,32(4):e12991. doi: 10.1111/dth. 12991. |
[39] | Lin N, Zhao X. Unique Cobb syndrome with Kaposi hemangioendothelioma/tufted angioma as dominant phenotype: a case report[J]. World J Pediatr Surg, 2023,6(4):e000695. doi: 10.1136/wjps⁃2023⁃000695. |
[40] | Clark MT, Brooks EL, Chong W, et al. Cobb syndrome: a case report and systematic review of the literature[J]. Pediatr Neurol, 2008,39(6):423⁃425. doi: 10.1016/j.pediatrneurol.2008.08.001. |
[41] | 张蕊蕊, 李秀云, 储照虎. Cobb综合征一例 [J] . 中华神经科杂志, 2021,54(4):388⁃391. doi: 10.3760/cma.j.cn113694⁃2020 0723⁃00564. |
[42] | Wang KH, Kupa J, Duffy KA, et al. Diagnosis and management of Beckwith⁃Wiedemann syndrome[J]. Front Pediatr, 2019,7:562. doi: 10.3389/fped.2019.00562. |
[43] | Al⁃Samkari H .Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care[J].Blood, 2020,137(7):888⁃895. doi: 10.1182/blood.2020008739. |
[44] | Bui TNPT, Corap A, Bygum A. Cutis marmorata telangiectatica congenita: a literature review[J]. Orphanet J Rare Dis, 2019,14(1):283. doi: 10.1186/s13023⁃019⁃1229⁃8. |
[45] | Russell BE, Kianmahd RR, Munster C, et al. Clinical findings in 39 individuals with Bohring⁃Opitz syndrome from a global patient⁃driven registry with implications for tumor surveillance and recurrence risk[J]. Am J Med Genet A, 2023,191(4):1050⁃1058. doi: 10.1002/ajmg.a.63125. |
[1] | Chen Haotian, Liu Lian, Zhang Ting, Liu Qingfeng, Li Xiaoxue, Diao Ping, Jiang Xian. Port-wine stains: mechanisms underlying the development and progression [J]. Chinese Journal of Dermatology, 2024, 57(7): 661-664. |
[2] | Diao Ping, Han Chenglong, Liu Lian, Zhou Hui, Li Erlong, Jiang Xian. Efficacy and influencing factors of hematoporphyrin monomethyl ether-mediated photodynamic therapy in the treatment of adult patients with port-wine stains: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(7): 595-600. |
[3] | Zhang Ting, Liu Lian, Chen Haotian, Wei Danfeng, Liu Xu, Diao Ping, Liu Qingfeng, Jiang Xian. Efficacy of 595-nm pulsed dye laser in the treatment of port‐wine stains in 155 infants and toddlers: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(7): 610-615. |
[4] | Zhang Sheng, Wang Xiuwei, Chen Jianyou, Deng Wei, Zhang Haihua, Zhang Gaolei, Liu Xiaoyan, Su Wei. Efficacy of hematoporphyrin monomethyl ether-mediated photodynamic therapy in the treatment of facial port-wine stains in 15 children with Sturge-Weber syndrome [J]. Chinese Journal of Dermatology, 2024, 57(7): 616-622. |
[5] | Jiang Xian, Liu Lian, Zhang Ting. Treatment of port-wine stains: current status and prospects [J]. Chinese Journal of Dermatology, 2024, 57(7): 590-594. |
[6] | The Consensus Development Expert Group of Hematoporphyrin Monomethyl Ether-mediated Photodynamic Therapy for Treating Port-wine Stains. Expert consensus on hematoporphyrin monomethyl ether-mediated photodynamic therapy for treating port-wine stains (2024) [J]. Chinese Journal of Dermatology, 2024, 57(7): 581-589. |
[7] | aser Cosmetology Group, Medical Aesthetics and Cosmetology Branch of Chinese Medical Association, Skin Care Product and Material Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment, Laser Group, Cosmetic and Plastic Surgeon Branch of Chinese Medical Doctor Association, Cosmetic Laser Group, Chinese Society of Dermatology. Guidelines for the diagnosis and treatment of adverse skin reactions to cosmetics (2024 edition) [J]. Chinese Journal of Dermatology, 2024, 57(6): 485-492. |
[8] | Wang Chen, Xue Chenhong, Song Jinghui, Li Jianguo, Li Zhenlu, Zhang Shoumin, Li Ming, Wang Jianbo. Adalimumab for the treatment of three cases of Blau syndrome in a pedigree [J]. Chinese Journal of Dermatology, 2024, 57(6): 553-556. |
[9] | China Dermatologist Association. Guidelines for the management of chronic pruritus (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 387-399. |
[10] | Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434. |
[11] | China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology. Diagnosis and treatment of erythrodermic psoriasis: a Chinese expert consensus statement (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 409-417. |
[12] | Mycology Group, Combination of Traditional and Western Medicine Dermatology, Chinese Antifungal-Resistant Dermatophytosis Expert Consensus Group. Expert consensus on the diagnosis, treatment, prevention and control of antifungal-resistant dermatophyte infections in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 418-425. |
[13] | Wang Yimeng, Wu Wenting, Zhang Qian, Zhang Chunlei, Li Weiwei. Clinical and pathological diagnoses of 389 patients with primary solid tumors localized in the perianal and external genitalia regions [J]. Chinese Journal of Dermatology, 2024, 57(4): 316-323. |
[14] | Ling Ming, Kong Xiangping, Huang Furong, Xu Jun, Zhao Menghua, Huang Li, Zhang Aimin. A case of Kindler syndrome: clinical and genetic analysis [J]. Chinese Journal of Dermatology, 2024, 57(4): 370-372. |
[15] | Wang Yukun, Liu Jie. Application of deep learning in non-neoplastic dermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220660-e20220660. |
|